Abstract:We have previously identified a human CD8+HLA-DR+ regulatory T cell subset with the ability to suppress proliferation of autologous PBMCs responder cells through cell contact and CTLA-4 co-inhibitory molecule. The present study characterizes the complete phenotype of CD8+HLA-DR+ Treg cells which showed great similarities with classical CD4+ cells expressing forkhead box P3 (FOXP3). The shared features included the expression of programmed cell death protein 1 (PD-1), T-cell immunoreceptor with Ig and ITIM domains (TIGIT), C-C chemokine receptor type 4 and 5 (CCR4 and CCR5), low expression of CD127, and a memory and effector-like phenotype. CD8+HLA-DR+ Treg-induced suppression on CD8+ responder T cells was abrogated by an anti-PD1 neutralizing antibody. Anti-PD-1 did not abrogate the suppressor effect induced on responder CD4+ T cells. In addition, CD8+HLA-DR+ Treg induced a preferential death on responder CD8+ T cells. This effect was not reversed by PD-1 neutralization. After activation, most CD8+HLA-DR+ Treg acquire programmed death-ligand 1 (PD-L1) expression. Interestingly, PD-L1 may induce apoptosis through CD80 expressed on activated CD8+ responder T cells. After PBMCs stimulation, CD8+HLA-DR+ Treg cells showed an increased frequency of IFN-γ and TNFα positive cells and higher degranulation. These data strongly argue against CD8+HLA-DR+ Treg being exhausted cells. Overall, the data presented in this study indicate that CD8+HLA-DR+ Treg and CD4+FOXP3+ Treg share phenotypic and functional features, which may provide cues to similar involvements in the control of antitumor immune responses and autoimmunity.

CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells

Analysis of Spurious Tones in Microwave Oscillators via the Hopf Bifurcation Concept

Engagement of B7 on Effector T Cells by Regulatory T Cells Prevents Autoimmune Disease.

CD70-mediated CD27 Expression Downregulation Contributed to the Regulatory B10 Cell Impairment in Rheumatoid Arthritis.

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

CD45 ligation expands Tregs by promoting interactions with DCs

Human CD8+HLA-DR+ Regulatory T Cells, Similarly to Classical CD4+Foxp3+ Cells, Suppress Immune Responses via PD-1/PD-L1 Axis

CD86 Is a Selective CD28 Ligand Supporting FoxP3+ Regulatory T Cell Homeostasis in the Presence of High Levels of CTLA-4

CD70 defines a subset of proinflammatory and CNS-pathogenic TH1/TH17 lymphocytes and is overexpressed in multiple sclerosis

CD70 identifies alloreactive T cells and represents a potential target for prevention and treatment of acute GvHD

Human CD4+CD25+CD127lowFOXP3+ regulatory T lymphocytes and CD4+CD25-FOXP3- conventional T lymphocytes: a differential transcriptome profile

Effects of Small-Molecule Inhibitors of TNFR2 Signaling Pathways on TNF-Mediated Expansion of CD4+FoxP3+ Regulatory T Cells

Phenotypic profiling of human induced regulatory T cells at early differentiation: insights into distinct immunosuppressive potential

Signaling pathway(s) of TNFR2 required for the immunoregulatory effect of CD4+Foxp3+ regulatory T cells

Interaction of Cd5 and Cd72 is Involved in Regulatory T and B Cell Homeostasis

High affinity chimeric antigen receptor signaling induces an inflammatory program in human regulatory T cells

CD74 supports accumulation and function of regulatory T cells in tumors

Ex Vivo Expanded Human Non-Cytotoxic CD8+CD45RClow/− Tregs Efficiently Delay Skin Graft Rejection and GVHD in Humanized Mice

Rapamycin Together with TGF-β1, IL-2 and IL-15 Induces the Generation of Functional Regulatory Γδt Cells from Human Peripheral Blood Mononuclear Cells

Modulation of Regulatory T Cell Activity by TNF Receptor Type II-Targeting Pharmacological Agents

T-reg transcriptomic signatures identify response to check-point inhibitors